Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon Treatment”

1,078 trials

Showing 20 of 1,078 results

Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Testing effectiveness (Phase 2)WithdrawnNCT04079088
What this trial is testing

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Biogen
Testing effectiveness (Phase 2)Study completedNCT00811395
What this trial is testing

Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 182
Testing effectiveness (Phase 2)Looking for participantsNCT05870475
What this trial is testing

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

Who this might be right for
Polycythemia Vera
Institute of Hematology & Blood Diseases Hospital, China 94
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Large-scale testing (Phase 3)Study completedNCT01390844
What this trial is testing

Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 282
Testing effectiveness (Phase 2)Active Not RecruitingNCT06694701
What this trial is testing

Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The EMBRACE Trial)

Who this might be right for
Sepsis
Hellenic Institute for the Study of Sepsis 75
Testing effectiveness (Phase 2)Study completedNCT00442572
What this trial is testing

SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 21
Early research (Phase 1)Study completedNCT06277167
What this trial is testing

A Phase I Study in Healthy Participants

Who this might be right for
Healthy Participants
Kexing Biopharm Co., Ltd. 35
Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Large-scale testing (Phase 3)Ended earlyNCT03547154
What this trial is testing

Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)

Who this might be right for
Chronic Myelogenous Leukemia
Merck Sharp & Dohme LLC 344
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07250594
What this trial is testing

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 126
Large-scale testing (Phase 3)Study completedNCT00099502
What this trial is testing

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 2,244
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Not applicableLooking for participantsNCT06222801
What this trial is testing

The 1st Tumor CytokinoTherapy Database (TCTD-1)

Who this might be right for
Oncology
OncoCareClinic 308 Ltd 5,000
Not applicableStudy completedNCT00002270
What this trial is testing

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
University of Miami
Large-scale testing (Phase 3)WithdrawnNCT01447394
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00083876
What this trial is testing

D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 500
Not applicableStudy completedNCT01413490
What this trial is testing

Hepatitis C Rimantadine and Antiviral Combination Therapy

Who this might be right for
Hepatitis C
The Leeds Teaching Hospitals NHS Trust 10
Not applicableUnknownNCT03158480
What this trial is testing

Safety and Efficacy of Immune Therapy for Condyloma

Who this might be right for
Condylomata Acuminata
Shenzhen Second People's Hospital 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation